Comparative activities of nickel(II) and zinc(II) complexes of asymmetric [NN'O] ligands as 26S proteasome inhibitors.
about
Targeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future.Recent advances in proteasome inhibitor discovery.Proteasome inhibitor patents (2010 - present).Synthesis and structures of bis-ligated zinc complexes supported by tridentate ketoimines that initiate L-lactide polymerization.HIF-1α Upregulation due to Depletion of the Free Ubiquitin Pool.Nickel and cadmium-induced SLBP depletion: A potential pathway to metal mediated cellular transformation.Novel metals and metal complexes as platforms for cancer therapyInhibition of the purified 20S proteasome by non-heme iron complexes.Effects of tethered ligands and of metal oxidation state on the interactions of cobalt complexes with the 26S proteasome.Unravelling mechanisms behind the biological activity of bis(S-citronellalthiosemicarbazonato)nickel(II).One pot synthesis of structurally different mono and dimeric Ni(II) thiosemicarbazone complexes and N-arylation on a coordinated ligand: a comparative biological study.Phosphatase-like activity, DNA binding, DNA hydrolysis, anticancer and lactate dehydrogenase inhibition activity promoting by a new bis-phenanthroline dicopper(II) complex.A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy.Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing.Synthesis and structure of a new trinuclear nickel(II) complex bridged by N-[3-(Dimethylamino)propyl]-N'-(2-hydroxyphenyl)oxamido: in vitro anticancer activities, and reactivities toward DNA and protein.Copper(II), cobalt(II) and nickel(II) complexes of lapachol: synthesis, DNA interaction, and cytotoxicity.Copper(II), cobalt(II) and nickel(II) complexes of juglone: synthesis, structure, DNA interaction and enhanced cytotoxicity.Synthesis and characterization of ML and ML2 metal complexes with amino acid substituted bis(2-picolyl)amine ligands
P2860
Q34195083-E30B4D6A-4F1C-43E7-B033-379A50650B9FQ34645067-79D227F0-A5D0-422D-9CB8-7F1A41EEEFB8Q35085938-1C990D61-6B64-4520-9D51-F62184C364ECQ35277634-58AEF688-1923-4F4A-97B4-2C99BAD06B57Q36075425-01E14A94-30F0-4ECA-B1A5-646AB97DE7E5Q36312177-D44FFBFE-659D-4F25-A7AF-4DE19CDC222EQ37137649-3A6F4358-9063-47F6-924D-750FFE62676EQ37217564-EEFBF12C-B42F-411A-AB7E-B068A9A827FBQ37304068-F4FF7AE7-CC47-439A-BA57-A8A0DFDD3498Q39023137-288EADE6-D99F-4C2E-BB5C-DC93A6821DCDQ39326028-C7AB1EEB-B7CA-4224-938D-92FEB966A2ECQ39525896-2346E28A-7234-4329-9B65-4193FEFFBB45Q43226621-E24A3D44-84E7-4881-900E-340966092809Q47631097-E3465D1F-6877-4867-95D1-405B6D5FA8A4Q51612807-0C178B93-E234-4B61-9AD6-F4C94EB8BB84Q52796720-48ADB920-8200-4CA2-9BC2-352EF7B2E9B4Q52849761-C2F280F3-9F14-4D9C-A620-5DDE66205C19Q58119874-23507D1E-5942-4417-84AC-76826629B96A
P2860
Comparative activities of nickel(II) and zinc(II) complexes of asymmetric [NN'O] ligands as 26S proteasome inhibitors.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Comparative activities of nick ...... as 26S proteasome inhibitors.
@ast
Comparative activities of nick ...... as 26S proteasome inhibitors.
@en
type
label
Comparative activities of nick ...... as 26S proteasome inhibitors.
@ast
Comparative activities of nick ...... as 26S proteasome inhibitors.
@en
prefLabel
Comparative activities of nick ...... as 26S proteasome inhibitors.
@ast
Comparative activities of nick ...... as 26S proteasome inhibitors.
@en
P2093
P2860
P356
P1433
P1476
Comparative activities of nick ...... s as 26S proteasome inhibitors
@en
P2093
Cláudio N Verani
Dajena Tomco
Mary Jane Heeg
Michael Frezza
Q Ping Dou
Qiuzhi Cindy Cui
Sarmad Sahiel Hindo
P2860
P304
P356
10.1021/IC900276G
P407
P577
2009-07-01T00:00:00Z